Citigroup’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-54
| Closed | -$201 | – | 4827 |
|
|
2022
Q4 | $201 | Hold |
54
| – | – | ﹤0.01% | 4794 |
|
|
2022
Q3 | $0 | Sell |
54
-1
| -2% | – | ﹤0.01% | 5185 |
|
|
2022
Q2 | $0 | Hold |
55
| – | – | ﹤0.01% | 5545 |
|
|
2022
Q1 | $0 | Buy |
55
+11
| +25% | – | ﹤0.01% | 5531 |
|
|
2021
Q4 | $0 | Buy |
+44
| New | – | ﹤0.01% | 5142 |
|